Eric Van Cutsem
Academic medical oncologist based at University Hospitals Leuven, Belgium, specializing in gastrointestinal cancers and contributing European clinical trial insights and interpretation.
Best podcasts with Eric Van Cutsem
Ranked by the Snipd community
6 snips
Mar 19, 2026 • 22min
HER2-Positive Gastrointestinal Cancers — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Dr Zev Wainberg, UCLA medical oncologist focused on gastroesophageal cancer; Prof Eric Van Cutsem, Leuven academic oncologist with European trial expertise; Dr Haley Ellis, MGH oncologist experienced in biliary tract HER2 disease. They discuss TIGIT and immunotherapy skepticism, sequencing and salvage HER2 strategies, rebiopsy and ctDNA after progression, CNS metastasis management, neoadjuvant HER2 approaches, and toxicity monitoring.
Mar 14, 2026 • 13min
HER2-Positive Gastrointestinal Cancers — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Prof Eric Van Cutsem, GI oncology professor from University Hospitals Leuven, shares trial-based perspectives on HER2 strategies. Dr Haley Ellis, medical oncologist at Mass General/Harvard, offers clinical viewpoints on HER2-positive biliary cancers. They discuss managing HER2 treatments with hyperbilirubinemia, cardiac monitoring with HER2 agents, sequencing targeted therapy versus chemoimmunotherapy, and testing choices for overlapping targets.
